<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37615735</PMID><DateCompleted><Year>2024</Year><Month>01</Month><Day>12</Day></DateCompleted><DateRevised><Year>2024</Year><Month>01</Month><Day>12</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1573-2649</ISSN><JournalIssue CitedMedium="Internet"><Volume>33</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation</Title><ISOAbbreviation>Qual Life Res</ISOAbbreviation></Journal><ArticleTitle>Prognostic factors for deterioration of quality of life one year after admission to ICU for severe SARS-COV2 infection.</ArticleTitle><Pagination><StartPage>123</StartPage><EndPage>132</EndPage><MedlinePgn>123-132</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s11136-023-03503-0</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">Patients with COVID-19 present long-term symptoms collectively known as "post-COVID syndrome". Long-term manifestations are more frequent in patients requiring admission to Intensive Care Units (ICU), but the risk factors for their development are still unknown. This study explores the quality of life of patients with severe COVID-19 one year after their discharge from ICU.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Prospective observational study including 106 patients admitted to the ICU of a tertiary care hospital between March and August 2020. We analysed quality of life using the EuroQol-5D index (EQ-5D). We evaluated as possible risk factors associated with a worse value of the EQ-5D index the medical record, the clinical situation at hospital admission, the clinical situation at ICU admission and evolution in the ICU. As a secondary objective, we explored the presence of other frequent symptoms.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Most patients (55.4%) reported that their quality of life worsened one year after admission. The mean perceived health status, on the EQ-VAS scale (0-100), was 70.4, with a median of 70 (RI 60-90). The median EQ-5D index was 0.91 (RI 0.76-1). The factors independently related to lower quality of life were female sex and duration of mechanical ventilation. Almost all (91%) of the patients had sequelae one year after discharge from the ICU. The most frequent manifestations were neuropsychiatric (71%).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Critically ill COVID-19 patients worsen their quality of life more than one year after discharge. Female sex and duration of mechanical ventilation predict a lower quality of life assessed by the EQ-5D index.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s), under exclusive licence to Springer Nature Switzerland AG.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Caamano</LastName><ForeName>E</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0003-0836-5226</Identifier><AffiliationInfo><Affiliation>Department of Anaesthesiology and Critical Care Medicine, Gregorio Maranon National Hospital, Madrid, Spain. estrelacaamano@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Velasco</LastName><ForeName>L</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology and Critical Care Medicine, Gregorio Maranon National Hospital, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garcia</LastName><ForeName>M V</ForeName><Initials>MV</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology and Critical Care Medicine, Gregorio Maranon National Hospital, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Asencio</LastName><ForeName>J M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Department of General Surgery, Gregorio Maranon National Hospital, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pi&#xf1;eiro</LastName><ForeName>P</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology and Critical Care Medicine, Gregorio Maranon National Hospital, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hortal</LastName><ForeName>J</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology and Critical Care Medicine, Gregorio Maranon National Hospital, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garutti</LastName><ForeName>I</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology and Critical Care Medicine, Gregorio Maranon National Hospital, Madrid, Spain.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D064888">Observational Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>08</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Qual Life Res</MedlineTA><NlmUniqueID>9210257</NlmUniqueID><ISSNLinking>0962-9343</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D012367">RNA, Viral</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="Y">Quality of Life</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012367" MajorTopicYN="N">RNA, Viral</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007362" MajorTopicYN="N">Intensive Care Units</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">EuroQol-5D</Keyword><Keyword MajorTopicYN="N">Long-COVID</Keyword><Keyword MajorTopicYN="N">Post-COVID</Keyword><Keyword MajorTopicYN="N">Quality of life</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>8</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>1</Month><Day>12</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>8</Month><Day>24</Day><Hour>13</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>8</Month><Day>24</Day><Hour>11</Hour><Minute>7</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37615735</ArticleId><ArticleId IdType="doi">10.1007/s11136-023-03503-0</ArticleId><ArticleId IdType="pii">10.1007/s11136-023-03503-0</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Carf&#xec;, A., Bernabei, R., Landi, F., &amp; for the Gemelli Against COVID-19 Post-Acute Care Study Group. Persistent Symptoms in Patients After Acute COVID-19. JAMA 324, 603 (2020).</Citation></Reference><Reference><Citation>Mahase, E. (2020). Covid-19: What do we know about &#x201c;long covid&#x201d;? BMJ, 370, m2815.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m2815</ArticleId><ArticleId IdType="pubmed">32665317</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiong, Q., et al. (2021). Clinical sequelae of COVID-19 survivors in Wuhan, China: A single-centre longitudinal study. Clinical Microbiology &amp; Infection, 27, 89&#x2013;95.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2020.09.023</ArticleId></ArticleIdList></Reference><Reference><Citation>The Writing Committee for the COMEBAC Study Group. (2021). Four-month clinical status of a cohort of patients after hospitalization for COVID-19. JAMA, 325, 1525&#x2013;1534.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2021.3331</ArticleId><ArticleId IdType="pmc">7970386</ArticleId></ArticleIdList></Reference><Reference><Citation>Martillo, M. A., et al. (2021). Postintensive care syndrome in survivors of critical illness related to coronavirus disease 2019: cohort study from a New York city critical care recovery clinic*. Critical Care Medicine, 49, 1427&#x2013;1438.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0000000000005014</ArticleId><ArticleId IdType="pubmed">33769771</ArticleId></ArticleIdList></Reference><Reference><Citation>Heesakkers, H., et al. (2022). Clinical outcomes among patients with 1-year survival following intensive care unit treatment for COVID-19. JAMA, 327, 559&#x2013;565.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2022.0040</ArticleId><ArticleId IdType="pubmed">35072716</ArticleId></ArticleIdList></Reference><Reference><Citation>Enfermedad por coronavirus (COVID-19): afecci&#xf3;n posterior a la COVID-19. https://www.who.int/es/news-room/questions-and-answers/item/coronavirus-disease-(covid-19)-post-covid-19-condition .</Citation></Reference><Reference><Citation>Hatch, R., et al. (2018). Anxiety, depression and post traumatic stress disorder after critical illness: A UK-wide prospective cohort study. Critical Care, 22, 310.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-018-2223-6</ArticleId><ArticleId IdType="pubmed">30466485</ArticleId><ArticleId IdType="pmc">6251214</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonz&#xe1;lez, J., et al. (2021). Pulmonary function and radiologic features in survivors of critical COVID-19. Chest, 160, 187&#x2013;198.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chest.2021.02.062</ArticleId><ArticleId IdType="pubmed">33676998</ArticleId></ArticleIdList></Reference><Reference><Citation>Batawi, S., et al. (2019). Quality of life reported by survivors after hospitalization for Middle East respiratory syndrome (MERS). Health and Quality of Life Outcomes, 17, 101.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12955-019-1165-2</ArticleId><ArticleId IdType="pubmed">31186042</ArticleId><ArticleId IdType="pmc">6560892</ArticleId></ArticleIdList></Reference><Reference><Citation>Luyt, C.-E., et al. (2012). Long-term outcomes of pandemic 2009 influenza A(H1N1)-associated severe ARDS. Chest, 142, 583&#x2013;592.</Citation><ArticleIdList><ArticleId IdType="doi">10.1378/chest.11-2196</ArticleId><ArticleId IdType="pubmed">22948576</ArticleId></ArticleIdList></Reference><Reference><Citation>Frithiof, R. et al. Critical Illness Polyneuropathy and Myopathy in COVID-19 Patients: A Prospective Observational Intensive Care Unit Cross-Sectional Cohort Study. https://www.researchsquare.com/article/rs-78038/v1 (2020) https://doi.org/10.21203/rs.3.rs-78038/v1 .</Citation></Reference><Reference><Citation>Griffiths, J., et al. (2013). An exploration of social and economic outcome and associated health-related quality of life after critical illness in general intensive care unit survivors: A 12-month follow-up study. Critical Care, 17, R100.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc12745</ArticleId><ArticleId IdType="pubmed">23714692</ArticleId><ArticleId IdType="pmc">3706775</ArticleId></ArticleIdList></Reference><Reference><Citation>Hopkins, R. O., Weaver, L. K., Chan, K. J., &amp; Orme, J. F. (2004). Quality of life, emotional, and cognitive function following acute respiratory distress syndrome. Journal of the International Neuropsychology Society, 10, 1005&#x2013;1017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S135561770410711X</ArticleId></ArticleIdList></Reference><Reference><Citation>Moreno-P&#xe9;rez, O., et al. (2021). Post-acute COVID-19 syndrome Incidence and risk factors: A Mediterranean cohort study. Journal of Infection, 82, 378&#x2013;383.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2021.01.004</ArticleId><ArticleId IdType="pubmed">33450302</ArticleId></ArticleIdList></Reference><Reference><Citation>Taboada, M., et al. (2022). Calidad de vida y s&#xed;ntomas persistentes tras hospitalizaci&#xf3;n por COVID-19. Estudio observacional prospectivo comparando pacientes con o sin ingreso en UCI. Revista Espa&#xf1;ola de Anestesiolog&#xed;a y Reanimaci&#xf3;n., 69, 326&#x2013;335.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.redar.2021.05.009</ArticleId><ArticleId IdType="pubmed">35760688</ArticleId><ArticleId IdType="pmc">9186450</ArticleId></ArticleIdList></Reference><Reference><Citation>Herridge, M. S. et al. One-year outcomes in survivors of the acute respiratory distress syndrome. The New England Journal of Medicine 11 (2003).</Citation></Reference><Reference><Citation>EuroQol - a new facility for the measurement of health-related quality of life. Health Policy 16, 199&#x2013;208 (1990).</Citation></Reference><Reference><Citation>Menges, D., et al. (2021). Burden of post-COVID-19 syndrome and implications for healthcare service planning: A population-based cohort study. PLoS ONE, 16, e0254523.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0254523</ArticleId><ArticleId IdType="pubmed">34252157</ArticleId><ArticleId IdType="pmc">8274847</ArticleId></ArticleIdList></Reference><Reference><Citation>Garrigues, E., et al. (2020). Post-discharge persistent symptoms and health-related quality of life after hospitalization for COVID-19. Journal of Infection, 81, e4&#x2013;e6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2020.08.029</ArticleId><ArticleId IdType="pubmed">32853602</ArticleId></ArticleIdList></Reference><Reference><Citation>Valent, A., Dudoignon, E., Ressaire, Q., D&#xe9;pret, F., &amp; Plaud, B. (2020). Three-month quality of life in survivors of ARDS due to COVID-19: A preliminary report from a French academic centre. Anaesthesia Critical Care and Pain Medicine, 39, 740&#x2013;741.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.accpm.2020.10.001</ArticleId></ArticleIdList></Reference><Reference><Citation>COVID-ICU Group on behalf of the REVA Network and the COVID-ICU Investigators. Clinical characteristics and day-90 outcomes of 4244 critically ill adults with COVID-19: a prospective cohort study. Intensive Care Medicine. 47, 60&#x2013;73 (2021).</Citation></Reference><Reference><Citation>Zhou, F., et al. (2020). Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: A retrospective cohort study. The Lancet, 395, 1054&#x2013;1062.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30566-3</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang, C., et al. (2020). Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet, 395, 497&#x2013;506.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30183-5</ArticleId></ArticleIdList></Reference><Reference><Citation>Petrilli, C. M., et al. (2020). Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: Prospective cohort study. The BMJ, 369, m1966.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m1966</ArticleId><ArticleId IdType="pubmed">32444366</ArticleId><ArticleId IdType="pmc">7243801</ArticleId></ArticleIdList></Reference><Reference><Citation>Sykes, D. L., et al. (2021). Post-COVID-19 symptom burden: What is long-COVID and how should we manage it? Lung, 199, 113&#x2013;119.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00408-021-00423-z</ArticleId><ArticleId IdType="pubmed">33569660</ArticleId><ArticleId IdType="pmc">7875681</ArticleId></ArticleIdList></Reference><Reference><Citation>Bai, F., et al. (2022). Female gender is associated with long COVID syndrome: A prospective cohort study. Clinical Microbiology &amp; Infection, 28(611), e9-611.e16.</Citation></Reference><Reference><Citation>Santab&#xe1;rbara, J., et al. (2021). Prevalence of anxiety in the COVID-19 pandemic: An updated meta-analysis of community-based studies. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 109, 110207.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pnpbp.2020.110207</ArticleId><ArticleId IdType="pubmed">33338558</ArticleId></ArticleIdList></Reference><Reference><Citation>Pun, B. T., et al. (2021). Prevalence and risk factors for delirium in critically ill patients with COVID-19 (COVID-D): A multicentre cohort study. The Lancet Respiratory Medicine, 9, 239&#x2013;250.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(20)30552-X</ArticleId><ArticleId IdType="pubmed">33428871</ArticleId><ArticleId IdType="pmc">7832119</ArticleId></ArticleIdList></Reference><Reference><Citation>Bwire, G. M. (2020). Coronavirus: Why men are more vulnerable to Covid-19 than women? Sn Comprehensive Clinical Medicine, 2, 874&#x2013;876.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s42399-020-00341-w</ArticleId><ArticleId IdType="pubmed">32838138</ArticleId><ArticleId IdType="pmc">7271824</ArticleId></ArticleIdList></Reference><Reference><Citation>Vadakedath, S., et al. (2021). Immunological aspects and gender bias during respiratory viral infections including novel Coronavirus disease-19 (COVID-19): A scoping review. Journal of Medical Virology, 93, 5295&#x2013;5309.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27081</ArticleId><ArticleId IdType="pubmed">33990972</ArticleId><ArticleId IdType="pmc">8242919</ArticleId></ArticleIdList></Reference><Reference><Citation>Ortona, E., &amp; Malorni, W. (2022). Long COVID: To investigate immunological mechanisms and sex/gender related aspects as fundamental steps for tailored therapy. European Respiratory Journal, 59, 2102245.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.02245-2021</ArticleId><ArticleId IdType="pubmed">34531277</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodr&#xed;guez-Rey, R., Garrido-Hernansaiz, H. &amp; Collado, S. Psychological Impact and Associated Factors During the Initial Stage of the Coronavirus (COVID-19) Pandemic Among the General Population in Spain. Frontiers in Psychology 11, (2020).</Citation></Reference><Reference><Citation>Mandal, S., et al. (2021). &#x2018;Long-COVID&#x2019;: A cross-sectional study of persisting symptoms, biomarker and imaging abnormalities following hospitalisation for COVID-19. Thorax, 76, 396&#x2013;398.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2020-215818</ArticleId><ArticleId IdType="pubmed">33172844</ArticleId></ArticleIdList></Reference><Reference><Citation>Zou, X., et al. (2020). Acute physiology and chronic health evaluation II score as a predictor of hospital mortality in patients of coronavirus disease 2019. Critical Care Medicine, 48, e657.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0000000000004411</ArticleId><ArticleId IdType="pubmed">32697506</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayoubkhani, D., et al. (2021). Post-covid syndrome in individuals admitted to hospital with covid-19: Retrospective cohort study. The BMJ, 372, n693.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n693</ArticleId><ArticleId IdType="pubmed">33789877</ArticleId><ArticleId IdType="pmc">8010267</ArticleId></ArticleIdList></Reference><Reference><Citation>Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study. The Lancet Respiratory Medicine. 10, 761&#x2013;775 (2022).</Citation></Reference><Reference><Citation>Townsend, L., et al. (2020). Persistent fatigue following SARS-CoV-2 infection is common and independent of severity of initial infection. PLoS ONE, 15, e0240784.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0240784</ArticleId><ArticleId IdType="pubmed">33166287</ArticleId><ArticleId IdType="pmc">7652254</ArticleId></ArticleIdList></Reference><Reference><Citation>Asadi-Pooya, A. A., et al. (2022). Long COVID syndrome-associated brain fog. Journal of Medical Virology, 94, 979&#x2013;984.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27404</ArticleId><ArticleId IdType="pubmed">34672377</ArticleId></ArticleIdList></Reference><Reference><Citation>Kayaaslan, B., et al. (2021). Post-COVID syndrome: A single-center questionnaire study on 1007 participants recovered from COVID-19. Journal of Medical Virology, 93, 6566&#x2013;6574.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27198</ArticleId><ArticleId IdType="pubmed">34255355</ArticleId><ArticleId IdType="pmc">8426910</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>